On August 30, 2018 Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, reported that an overview of the company’s business strategy and commercial and development-stage programs will be given at two upcoming conferences being held in New York on September 5th and September 6th (Press release, Spectrum Pharmaceuticals, AUG 30, 2018, View Source [SID1234529178]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
20th Annual Rodman & Renshaw Global Investment Conference
When: Wednesday, September 5, 2018 at 10:25 AM ET
Baird’s 2018 Global Healthcare Conference
When: Thursday, September 6, 2018 at 1:25 PM ET
The presentations will be webcast live and may be accessed by visiting Spectrum’s website at View Source